Sir Gregory Winter

Science Partner

Sir Gregory Winter, Nobel prize laureate, inventor of the technology leading to Humira ($18BN sales in 2017, the world’s greatest grossing drug) and founder of three companies. Master of Trinity College, Cambridge University.

Sir Gregory Winter is the inventor of the technology that led to Humira (Adalimumab), the first fully human antibody blockbuster and the best-selling drug worldwide in 2017 ($18BN sales) and was awarded the Nobel prize for his pioneering work in using phage display for the directed evolution of antibodies, with the aim of producing new therapeutics.

Sir Gregory’s development of technologies for making pharmaceutical antibodies by genetic engineering have led to many of the world’s top-selling pharmaceutical treatments for cancer and immune disorders, also including the “humanised” antibodies Herceptin (for treatment of breast cancer) and Lucentis (for treatment of wet acute macular degeneration). In order to see his technologies applied, Sir Gregory founded several successful start-up companies. Sir Gregory was knighted for his services to Molecular Biology in 2004 and his other awards include a Royal Medal in 2011 and the Nobel Prize for Chemistry in 2018. Sir Gregory is a Fellow of The Royal Society.